Diffusion Pharmaceuticals

Get Full Access

Description

  • Diffusion Pharmaceuticals is a clinical stage company focused on improving the effectiveness of standard-of-care therapies for life-threatening treatment-resistant solid cancerous tumors, without adding harmful side effects. The company is developing its lead drug, trans sodium crocetinate (TSC), which has received Orphan Drug Designation from the FDA for use in a number of cancers in which tumor hypoxia (oxygen deprivation) diminishes the efficacy of current treatments. TSC targets the cancers hypoxic micro-environment, re-oxygenating treatment-resistant tissue and making the cancerous cells more vulnerable to the therapeutic effects of conventional radiation and chemotherapy. The company is poised to begin a pivotal phase 3 trial in Glioblastoma (GBM) in 2016. Other programs include planned phase 2/3 trials in pancreatic cancer and brain metastases. Because TSCs novel mechanism safely re-oxygenates a wide range of tumor types, its use is not limited to a specific tumor tissue, but has the potential to treat numerous life-threatening cancers.
  • location

    Headquarters:2020 Avon Court Suite 4, Charlottesville, Virginia, United States

    More
  • Diffusion Pharmaceuticals phone

    Phone Number: +1 434-220-0718

  • Diffusion Pharmaceuticals website

    Website: https://www.diffusionpharma.com

  • Diffusion Pharmaceuticals employees

    Employees:12

  • Diffusion Pharmaceuticals revenue

    Revenue:$1 - 10M

  • Diffusion Pharmaceuticals legal name

    Legal Name:Diffusion Pharmaceuticals

  • Diffusion Pharmaceuticals's Social Media

    Diffusion Pharmaceuticals linkedin Diffusion Pharmaceuticals facebook Diffusion Pharmaceuticals twitter
  • done Is this data correct?
  • |  NAICS Code: 325412  |

    Show More
Person level website identification

CEO for Diffusion Pharmaceuticals

Bob Cobuzzi

Chief Executive Officer And Board Member

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Chris Galloway

Chief Medical Officer

William Hornung

Chief Financial Officer

Harry Cook

Vice President, Clinical Operations

Kelly Arscott

Head Of Clinical Operations

Veena Rao-Mirmira

Director Research And Development

Frequently Asked Questions regarding Diffusion Pharmaceuticals

  • Where are Diffusion Pharmaceuticals's Headquarters?

    Diffusion Pharmaceuticals's Headquarters are in 2020 Avon Court Suite 4,Charlottesville,Virginia,United States

  • What is Diffusion Pharmaceuticals's phone number?

    Diffusion Pharmaceuticals's phone number is +1 434-220-0718

  • What is Diffusion Pharmaceuticals's official website?

    Diffusion Pharmaceuticals's official website is https://www.diffusionpharma.com

  • What is Diffusion Pharmaceuticals's Revenue?

    Diffusion Pharmaceuticals's revenue is $1 - 10M

  • What is Diffusion Pharmaceuticals's NAICS code?

    Diffusion Pharmaceuticals's NAICS code is 325412

  • How many employees are working in Diffusion Pharmaceuticals

    Diffusion Pharmaceuticals has 12 employees

  • What is Diffusion Pharmaceuticals's Industry?

    Diffusion Pharmaceuticals is in the industry of Pharmaceuticals

  • Who is Diffusion Pharmaceuticals's CEO?

    Diffusion Pharmaceuticals's CEO is Bob Cobuzzi

Company Directory